export type BlogPost = {
  slug: string;
  title: string;
  description: string;
  category: string;
  readingTime: string;
  publishedAt: string; // ISO
  updatedAt: string;
  author: { name: string; role: string };
  keywords: string[];
  // Structured content — each section renders as <h2> + paragraphs.
  sections: Array<{ heading: string; paragraphs: string[] }>;
};

const DEFAULT_AUTHOR = { name: 'Dr. Andrei Ionescu', role: 'Head of Scientific Content, EuroPeptide Pro' };

export const BLOG_POSTS: BlogPost[] = [
  {
    slug: 'bpc-157-vs-tb-500',
    title: 'BPC-157 vs TB-500: Research Peptide Comparison',
    description: 'A side-by-side research comparison of BPC-157 and TB-500 — mechanisms, half-life, study endpoints, and why many protocols combine the two.',
    category: 'Healing & Recovery',
    readingTime: '7 min',
    publishedAt: '2026-03-10',
    updatedAt: '2026-04-24',
    author: DEFAULT_AUTHOR,
    keywords: ['bpc-157 vs tb-500', 'peptide comparison', 'regenerative peptides', 'research peptide protocol'],
    sections: [
      {
        heading: 'Overview',
        paragraphs: [
          'BPC-157 and TB-500 are the two most frequently cited regenerative research peptides. They act through complementary mechanisms, which is why many preclinical protocols study them either separately (to isolate effects) or as a combined blend (to examine additive tissue-repair outcomes).',
          'Both peptides target tissue repair, but via different molecular routes — BPC-157 via growth-factor receptor interaction and angiogenic modulation, TB-500 via G-actin sequestration and cell-migration facilitation.',
        ],
      },
      {
        heading: 'BPC-157 Mechanism',
        paragraphs: [
          'BPC-157 (Body Protection Compound 157) is a 15-amino-acid fragment derived from a protective protein found in the stomach. Research shows it upregulates VEGFR-2 expression, accelerating angiogenesis and endothelial repair. Additional mechanisms include modulation of the nitric-oxide (NO) system and interaction with the dopaminergic and serotonergic systems relevant to gut-lining integrity.',
          'Primary research endpoints for BPC-157 include tendon-to-bone healing, ligament repair, gastrointestinal barrier restoration, and attenuation of inflammatory cytokines in soft-tissue injury models.',
        ],
      },
      {
        heading: 'TB-500 Mechanism',
        paragraphs: [
          'TB-500 is a synthetic fragment of Thymosin Beta-4, a naturally occurring 43-amino-acid peptide abundant in wound-repair tissue. Its signature biological activity is binding G-actin monomers, preventing premature polymerization and thereby facilitating cell migration to injury sites.',
          'TB-500 research commonly focuses on cardiac remodeling post-ischemia, corneal repair, dermal wound closure, and skeletal-muscle regeneration. Its longer systemic half-life makes it suitable for extended recovery protocols.',
        ],
      },
      {
        heading: 'Head-to-Head: What Research Distinguishes Them',
        paragraphs: [
          'Onset: BPC-157 tends to produce earlier anti-inflammatory readouts in rodent models; TB-500 shows effects more gradually but at greater tissue depth. Distribution: BPC-157 is often studied in localized gut and tendon work; TB-500 in systemic cardiac and vascular models. Combination protocols leverage both — a typical research blend vial contains 5 mg of each.',
          'When designing a study, isolate the peptide-specific contribution by running three arms — BPC-157 only, TB-500 only, and the combined blend. This lets you decompose additive from synergistic effects.',
        ],
      },
      {
        heading: 'Storage, Reconstitution, Compliance',
        paragraphs: [
          'Both peptides ship lyophilized. Reconstitute with bacteriostatic water, store at 2–8 °C post-reconstitution, and avoid repeated freeze/thaw cycles. All products sold by EuroPeptide Pro are strictly for laboratory research and are not for human or veterinary use.',
        ],
      },
    ],
  },
  {
    slug: 'what-is-retatrutide',
    title: 'What Is Retatrutide? The Triple Agonist Research Peptide',
    description: 'Retatrutide is the first research-grade triple agonist targeting GLP-1, GIP, and glucagon receptors. Here is what the current peer-reviewed literature describes.',
    category: 'Weight Loss',
    readingTime: '6 min',
    publishedAt: '2026-03-18',
    updatedAt: '2026-04-24',
    author: DEFAULT_AUTHOR,
    keywords: ['retatrutide', 'triple agonist', 'glp-1 gip glucagon', 'metabolic research peptide'],
    sections: [
      {
        heading: 'Retatrutide at a Glance',
        paragraphs: [
          'Retatrutide (LY3437943) is the first peptide agonist to simultaneously activate GLP-1, GIP, and glucagon receptors. It sits downstream of Semaglutide (GLP-1 monotherapy) and Tirzepatide (dual GIP/GLP-1), extending incretin-family research into the glucagon-receptor arm.',
          'Glucagon-receptor activation — counterintuitive as it sounds for a weight-management compound — is hypothesized to further enhance lipid oxidation and energy expenditure beyond what GIP + GLP-1 alone achieves.',
        ],
      },
      {
        heading: 'Published Preclinical Findings',
        paragraphs: [
          'Preclinical and early-phase clinical data reviewed to date suggest dose-dependent reductions in body weight at magnitudes exceeding those of Tirzepatide. Effects on lipid profile and hepatic steatosis markers have been reported as particularly pronounced, aligning with the glucagon-receptor mechanism of action.',
          'For research purposes, Retatrutide is supplied lyophilized in 5 mg and 10 mg vials, allowing flexible titration protocols.',
        ],
      },
      {
        heading: 'How Researchers Design Comparisons',
        paragraphs: [
          'A robust research design includes at minimum three arms: Semaglutide (GLP-1 only), Tirzepatide (GIP + GLP-1), and Retatrutide (all three). Body weight, lipid panel, hepatic enzyme markers, and thermogenic indicators (e.g., UCP-1 expression in adipose) are typical endpoints.',
          'All peptides in these protocols should be sourced from the same supplier and verified by HPLC + MS to eliminate purity as a confounder.',
        ],
      },
      {
        heading: 'Compliance Note',
        paragraphs: [
          'Retatrutide is provided strictly for laboratory research. It is not approved for human therapeutic use in any jurisdiction as of the publication date of this article.',
        ],
      },
    ],
  },
  {
    slug: 'how-to-reconstitute-research-peptides',
    title: 'How to Reconstitute Research Peptides: Step-by-Step Guide',
    description: 'Lab-grade reconstitution protocol for lyophilized research peptides — solvent selection, technique, storage, and common pitfalls.',
    category: 'Protocols',
    readingTime: '5 min',
    publishedAt: '2026-02-22',
    updatedAt: '2026-04-24',
    author: DEFAULT_AUTHOR,
    keywords: ['peptide reconstitution', 'bacteriostatic water peptide', 'how to reconstitute bpc-157', 'peptide mixing guide'],
    sections: [
      {
        heading: 'Solvent Selection',
        paragraphs: [
          'Most lyophilized research peptides are reconstituted with bacteriostatic water — sterile water containing 0.9% benzyl alcohol as a preservative. This allows multi-dose vial use for up to 28 days post-reconstitution when refrigerated.',
          'A small subset of peptides (e.g., certain hydrophobic sequences or copper-bound peptides) require sterile 0.9% saline or specialized diluents. Always check supplier-specific recommendations on the Certificate of Analysis.',
        ],
      },
      {
        heading: 'Step-by-Step Procedure',
        paragraphs: [
          '1. Sanitize the rubber stopper of both the peptide vial and the bacteriostatic water vial with a 70% IPA prep pad.',
          '2. Using a sterile 1 ml insulin syringe (29G), draw the desired volume of bacteriostatic water.',
          '3. Slowly inject the water into the peptide vial, angling the needle so the stream runs down the inner wall rather than striking the lyophilized powder directly. This minimizes mechanical agitation.',
          '4. Gently swirl the vial — do not shake — until the powder fully dissolves. This typically takes 30–60 seconds.',
          '5. Label the vial with reconstitution date and final concentration. Store at 2–8 °C.',
        ],
      },
      {
        heading: 'Calculating Concentration',
        paragraphs: [
          'Concentration = peptide mass ÷ solvent volume. Example: 5 mg peptide in 2 ml bacteriostatic water → 2.5 mg/ml (2500 µg/ml). If the research protocol calls for a 250 µg dose, draw 0.1 ml (100 µl, or 10 units on a 1 ml insulin syringe).',
          'For more complex calculations, use our free <a href="/calculator">peptide reconstitution calculator</a>.',
        ],
      },
      {
        heading: 'Common Mistakes',
        paragraphs: [
          'Shaking instead of swirling, using non-sterile water, skipping the alcohol-swab step, letting the reconstituted vial sit at room temperature for extended periods, and re-using syringes between peptides are the most frequent errors. Each introduces either mechanical peptide fragmentation or contamination risk.',
        ],
      },
    ],
  },
  {
    slug: 'glp-1-peptide-family-guide',
    title: 'The GLP-1 Peptide Family: Semaglutide, Tirzepatide, Retatrutide',
    description: 'How the GLP-1 receptor agonist research peptide family evolved from Liraglutide to Retatrutide — mechanisms, comparisons, and study design.',
    category: 'Weight Loss',
    readingTime: '8 min',
    publishedAt: '2026-01-30',
    updatedAt: '2026-04-24',
    author: DEFAULT_AUTHOR,
    keywords: ['glp-1 family', 'semaglutide tirzepatide retatrutide', 'incretin research', 'metabolic peptides'],
    sections: [
      {
        heading: 'The Incretin Revolution',
        paragraphs: [
          'Incretin research — particularly into GLP-1 receptor agonists — has reshaped metabolic science over the past two decades. The evolution from short-acting native GLP-1 to daily Liraglutide, weekly Semaglutide, dual-agonist Tirzepatide, and tri-agonist Retatrutide represents successive iterations of peptide engineering aimed at greater potency, longer half-life, and multi-receptor engagement.',
        ],
      },
      {
        heading: 'Liraglutide and Semaglutide (GLP-1 Monotherapy)',
        paragraphs: [
          'Liraglutide, administered daily, was the first major step beyond native GLP-1 — its fatty-acid side chain prolongs binding to albumin and extends half-life from minutes to hours. Semaglutide extended this further via additional amino-acid substitutions, achieving a week-long half-life suitable for once-weekly research dosing.',
          'Both compounds remain the comparator standard for any study introducing newer incretin peptides.',
        ],
      },
      {
        heading: 'Tirzepatide (Dual GIP + GLP-1)',
        paragraphs: [
          'Tirzepatide adds GIP-receptor activity to the GLP-1 mechanism. GIP activation appears to amplify GLP-1 signaling in adipose and pancreatic tissue while contributing independent effects on insulin secretion. Preclinical research shows greater body-composition effects than GLP-1 monotherapy at equivalent glycemic endpoints.',
        ],
      },
      {
        heading: 'Retatrutide (Triple GLP-1 + GIP + Glucagon)',
        paragraphs: [
          'Retatrutide adds glucagon-receptor activation on top of the dual mechanism. Early research suggests this unlocks additional lipid oxidation and energy expenditure beyond what incretin receptor activity alone can achieve — see our <a href="/blog/what-is-retatrutide">dedicated Retatrutide article</a> for deeper detail.',
        ],
      },
      {
        heading: 'Designing Cross-Family Comparisons',
        paragraphs: [
          'Any cross-family research should (a) use equal molar doses where possible, (b) confirm purity across peptides via HPLC, (c) pair each arm with the same amylin analog (Cagrilintide) if adjunct satiety effects are under investigation. All peptides in this family ship from EuroPeptide Pro with matched batch testing.',
        ],
      },
    ],
  },
  {
    slug: 'cjc-1295-ipamorelin-synergy',
    title: 'CJC-1295 + Ipamorelin: Why Researchers Stack Them',
    description: 'GHRH analog plus ghrelin-receptor agonist — the mechanistic rationale for combining CJC-1295 and Ipamorelin in GH-axis research.',
    category: 'Muscle Growth',
    readingTime: '5 min',
    publishedAt: '2026-02-08',
    updatedAt: '2026-04-24',
    author: DEFAULT_AUTHOR,
    keywords: ['cjc-1295 ipamorelin', 'gh secretagogue combo', 'growth hormone research'],
    sections: [
      {
        heading: 'Two Receptors, One Pulse',
        paragraphs: [
          'Endogenous growth-hormone release is governed by two pituitary inputs: GHRH (positive) and somatostatin (negative), modulated by ghrelin-receptor activity. CJC-1295 activates GHRH receptors; Ipamorelin activates ghrelin (GHSR) receptors. Combining them targets both positive pathways simultaneously and produces GH pulses of larger amplitude than either alone in research models.',
        ],
      },
      {
        heading: 'DAC vs No-DAC',
        paragraphs: [
          'CJC-1295 is supplied with or without Drug Affinity Complex (DAC). DAC extends half-life from minutes (No-DAC, a.k.a. Mod GRF 1-29) to over a week. No-DAC is preferred for research protocols that aim to preserve endogenous pulse architecture; DAC is preferred for studies requiring sustained systemic GHRH-receptor occupancy.',
        ],
      },
      {
        heading: 'Why Ipamorelin Specifically',
        paragraphs: [
          'Among ghrelin-receptor agonists (GHRP-2, GHRP-6, Hexarelin, Ipamorelin), Ipamorelin stands out for its selectivity — minimal cortisol or prolactin elevation at research doses. This makes it a "clean" secretagogue for isolating GH-axis effects from stress-hormone confounders.',
        ],
      },
      {
        heading: 'Research Protocol Notes',
        paragraphs: [
          'Research protocols commonly study 100–200 µg of each compound as an aligned pulse. For reconstitution and dosing, see our <a href="/blog/how-to-reconstitute-research-peptides">reconstitution guide</a> and <a href="/calculator">calculator</a>. For laboratory research use only.',
        ],
      },
    ],
  },
  {
    slug: 'epitalon-longevity-research',
    title: 'Epitalon and Longevity: What the Research Actually Says',
    description: 'A survey of the peer-reviewed literature on Epitalon (Epithalon) — telomerase activation, circadian effects, and longevity research in model organisms.',
    category: 'Anti-Aging',
    readingTime: '6 min',
    publishedAt: '2026-02-14',
    updatedAt: '2026-04-24',
    author: DEFAULT_AUTHOR,
    keywords: ['epitalon research', 'epithalon longevity', 'telomerase peptide', 'pineal peptide'],
    sections: [
      {
        heading: 'From Pineal Extract to Synthetic Tetrapeptide',
        paragraphs: [
          'Epitalon (also spelled Epithalon) is the synthetic tetrapeptide Ala-Glu-Asp-Gly, derived from a peptide sequence identified in pineal gland extract (epithalamin). Russian research groups first characterized its effects in the 1980s and subsequently published decades of peer-reviewed work in animal and cell-culture models.',
        ],
      },
      {
        heading: 'Telomerase and Telomere Research',
        paragraphs: [
          'The most-cited Epitalon finding is its ability to activate telomerase in somatic cells — a property typically restricted to germ cells and certain stem-cell populations. In published research, this has been linked to extension of telomere length and postponement of cellular senescence markers.',
        ],
      },
      {
        heading: 'Circadian and Endocrine Effects',
        paragraphs: [
          'Beyond telomere research, Epitalon is studied for restoration of night-time melatonin amplitude in aged animals, normalization of cortisol rhythm, and modulation of sex-steroid production. These effects likely cascade from the pineal-gland origin of its parent peptide.',
        ],
      },
      {
        heading: 'Study Design Considerations',
        paragraphs: [
          'Epitalon is typically administered in short research cycles (10–20 days) rather than continuously, mirroring the protocols used in published literature. Available in 10 mg, 50 mg, and 100 mg vials for flexibility across study sizes.',
        ],
      },
    ],
  },
  {
    slug: 'storing-research-peptides',
    title: 'Storing Research Peptides: Temperature, Stability, Shelf Life',
    description: 'Temperature ranges, freeze/thaw effects, reconstituted-vial stability, and shelf-life guidance for lyophilized research peptides.',
    category: 'Protocols',
    readingTime: '4 min',
    publishedAt: '2026-02-28',
    updatedAt: '2026-04-24',
    author: DEFAULT_AUTHOR,
    keywords: ['peptide storage', 'peptide shelf life', 'freeze thaw peptide', 'peptide stability'],
    sections: [
      {
        heading: 'Lyophilized (Unreconstituted) Vials',
        paragraphs: [
          'Lyophilized peptides are at their most stable form. Store sealed vials at −20 °C for long-term preservation (24+ months for most sequences). Short-term storage at 2–8 °C is acceptable for weeks but not months. Avoid direct sunlight, humidity, and temperature cycling.',
        ],
      },
      {
        heading: 'Reconstituted Vials',
        paragraphs: [
          'Once reconstituted with bacteriostatic water, peptide stability drops sharply. Refrigerate at 2–8 °C and use within 28 days for most sequences, or within 14 days for more labile compounds (e.g., IGF-1 variants). Do not freeze reconstituted vials — ice crystal formation damages peptide structure.',
        ],
      },
      {
        heading: 'Freeze/Thaw Cycles',
        paragraphs: [
          'Repeated freeze/thaw of lyophilized vials is usually tolerated for 2–3 cycles, but is not advised as a regular practice. If longer-term research storage is needed, consider aliquoting into smaller vials pre-freeze to minimize cycles per batch.',
        ],
      },
      {
        heading: 'Documentation',
        paragraphs: [
          'Label every vial with (1) reconstitution date, (2) concentration, (3) solvent used, (4) storage location. Maintain a freezer log to track batch-level storage history — essential for reproducibility and audit trails.',
        ],
      },
    ],
  },
  {
    slug: 'ghk-cu-copper-peptide-research',
    title: 'GHK-Cu: The Copper Peptide in Dermal and Wound Research',
    description: 'GHK-Cu is the most-cited copper-peptide research compound. Mechanism, research applications, and vial sizing guidance.',
    category: 'Healing & Recovery',
    readingTime: '5 min',
    publishedAt: '2026-01-22',
    updatedAt: '2026-04-24',
    author: DEFAULT_AUTHOR,
    keywords: ['ghk-cu', 'copper peptide research', 'collagen peptide', 'dermal research'],
    sections: [
      {
        heading: 'What Makes GHK-Cu Unique',
        paragraphs: [
          'GHK-Cu is the naturally occurring complex of the tripeptide glycyl-L-histidyl-L-lysine with a copper ion. Its small size, strong copper affinity, and broad gene-regulatory activity make it the benchmark research tool in dermal biology and wound-repair studies.',
        ],
      },
      {
        heading: 'Published Research Directions',
        paragraphs: [
          'GHK-Cu upregulates collagen and elastin synthesis in fibroblast cultures, modulates expression of dozens of metabolic and ECM-remodeling genes, and exhibits antioxidant activity in reactive-oxygen-species assays. Research spans dermal aging, wound healing, hair-follicle biology, and systemic cytoprotective effects.',
        ],
      },
      {
        heading: 'Choosing a Vial Size',
        paragraphs: [
          'Vials of 50 mg, 100 mg, and 200 mg support different study durations. Smaller labs running short pilot studies prefer 50 mg; multi-experiment programs benefit from 200 mg bulk vials. All are HPLC-verified and shipped with reference COA.',
        ],
      },
    ],
  },
  {
    slug: 'peptide-coa-explained',
    title: 'Certificate of Analysis (COA): How to Read It',
    description: 'A researcher-friendly walkthrough of peptide COA documents — HPLC purity, mass-spec identity, residual solvents, and what to watch for.',
    category: 'Quality Assurance',
    readingTime: '5 min',
    publishedAt: '2026-03-02',
    updatedAt: '2026-04-24',
    author: DEFAULT_AUTHOR,
    keywords: ['peptide coa', 'hplc purity', 'mass spectrometry peptide', 'research peptide quality'],
    sections: [
      {
        heading: 'What a COA Is',
        paragraphs: [
          'A Certificate of Analysis (COA) is the laboratory document attesting that a specific batch of peptide meets declared identity and purity specifications. It is issued by an independent testing laboratory — ideally one unaffiliated with the supplier — and should cover HPLC purity, mass-spectrometry identity confirmation, and residual-solvent / moisture data.',
        ],
      },
      {
        heading: 'HPLC Purity',
        paragraphs: [
          'High-Performance Liquid Chromatography separates the peptide peak from impurities. Look for ≥98% purity as a minimum research standard; ≥99% for high-precision protocols. The chromatogram should show a sharp, narrow main peak with no significant shoulders.',
        ],
      },
      {
        heading: 'Mass Spectrometry',
        paragraphs: [
          'MS confirms that the purified peak matches the expected molecular weight of the target peptide sequence. A match within 1 Da of theoretical is typical. This rules out sequence errors, oxidation, or deamidation products that HPLC alone cannot always distinguish.',
        ],
      },
      {
        heading: 'Residual Solvents, Moisture, and Bioburden',
        paragraphs: [
          'Residual TFA (trifluoroacetic acid), acetonitrile, water content, and bioburden (bacterial / endotoxin load where tested) round out the QC panel. For research protocols involving cell culture or in-vivo work, low endotoxin is particularly important.',
        ],
      },
    ],
  },
  {
    slug: 'ordering-research-peptides-in-europe',
    title: 'Ordering Research Peptides in Europe: Compliance & Logistics',
    description: 'EU-specific guidance on sourcing research peptides — compliance framework, cold-chain shipping, customs considerations, and supplier evaluation.',
    category: 'Compliance',
    readingTime: '6 min',
    publishedAt: '2026-03-20',
    updatedAt: '2026-04-24',
    author: DEFAULT_AUTHOR,
    keywords: ['buy research peptides europe', 'eu peptide supplier', 'peptide customs eu', 'research peptide compliance'],
    sections: [
      {
        heading: 'Research-Use Framework in the EU',
        paragraphs: [
          'In the European Union, research peptides are sold exclusively for laboratory research purposes. They are not registered medicinal products and may not be promoted, labeled, or distributed for human or veterinary therapeutic use. Suppliers must clearly state research-only intent; researchers are responsible for ensuring the compound is used in a compliant laboratory setting.',
        ],
      },
      {
        heading: 'EU-Based vs Non-EU Suppliers',
        paragraphs: [
          'Sourcing from an EU-based supplier eliminates customs delays, import-VAT surprises, and the cold-chain integrity risks that come with longer international shipments. EuroPeptide Pro ships from Bucharest across all EU member states, typically within 24 hours for in-stock SKUs.',
        ],
      },
      {
        heading: 'Cold-Chain and Packaging',
        paragraphs: [
          'Lyophilized peptides tolerate ambient transit for several days without measurable degradation. However, for labile peptides (IGF-1 variants, certain GH secretagogues), cold-chain shipping with phase-change gel packs preserves full research-grade potency. Discreet, unbranded outer packaging is the industry norm.',
        ],
      },
      {
        heading: 'Evaluating a Supplier',
        paragraphs: [
          'Key questions: Is a batch-level COA issued by an independent lab? What is the purity floor (98% vs 99%)? Is the company transparent about lab partners, testing cadence, and quality procedures? Is shipping tracked across borders? A credible EU supplier provides clear answers to all of the above.',
        ],
      },
    ],
  },
];

export const blogPostBySlug = (slug: string): BlogPost | undefined =>
  BLOG_POSTS.find((p) => p.slug === slug);
